Funding profile · Patient access services
Medmonk
A 2012 Y Combinator and Rock Health company with small, mostly database-reported seed money and no SEC Form D on record. Its scale is better measured by operations than by capital raised.
$170KTotal raised, CB Insights estimate
$120KY Combinator seed, Tracxn estimate
$150KLast raise, Oct 2016, CB Insights and PitchBook
0Form D filings found
Data as of September 22, 2026. Company-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 2012 | Y Combinator, Winter 2012 | $120K (estimate) | Y Combinator | Tracxn |
| 2012 | Rock Health seed | Not disclosed | Rock Health | Tracxn |
| Oct 2016 | Seed | $150K (database); INR 1 crore (news item) | Two Indian investors named in a news item: Mohit Goel and Sudip Bandopadhyay | CB Insights, PitchBook |
| Jun 2025 | Secondary transaction | Not disclosed | Not disclosed | PitchBook |
| Undated | Minority investor listed | None attached | Andreessen Horowitz, per PitchBook only | Unconfirmed |
What the filings show
Medmonk · Form D · none found
- Searched
- Parsed SEC Form D records and EDGAR Form D mentions for the company name
- Result
- No filings by Medmonk and no investment vehicle naming it
- Related persons
- Not applicable
- Filing
- SEC EDGAR, no CIK identified
Reading the filings
- No filing, so no verified amount.Every dollar figure on this page comes from data aggregators. Tracxn puts total funding at $120K over two rounds, CB Insights at $170K with $150K last raised, and PitchBook at $150K. The three do not reconcile: $120K plus $150K is $270K, not $170K.
- The 2016 round lines up with a news item.PitchBook dates a seed round to Oct 10, 2016. A news item on CB Insights dated Oct 26, 2016 reports INR 1 crore, which is 10 million rupees. At about 67 rupees to the dollar, our arithmetic gives roughly $150K, matching the database figure. The item does not say the pitched company is this one, so the match rests on name, amount and timing.
- One investor claim stands alone.PitchBook lists Andreessen Horowitz as an investor but attaches no round, date or amount. The company, Y Combinator and Tracxn do not mention it.
- Ownership after 2025 is unknown.A June 2025 secondary transaction is recorded with no amount or buyer. Secondary sales of existing shares would not require a Form D from the company, so silence in EDGAR does not rule it out.
- Small early capital, larger operation.PitchBook gives 60 employees; MTEC lists the company as 1 to 50. Against $170K of reported outside money, that suggests the business has been funded largely by customer revenue, though no revenue figure is public.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Named brand program | XEMBIFY copay portal for Grifols, administered by Medmonk, up to $10,000 per patient per year (archived Mar 2025) | Partner-stated |
| Program history | Gamunex-C program site with 48 Internet Archive captures, Oct 2014 to Apr 2026 | Internet Archive |
| Customer tenure | Unnamed brands cite 6 and 7 year relationships; company cites 7-year average brand retention and 7 brand launches in 2025 | Company-stated |
| Business model | Pharma manufacturers pay for hub and copay services in rare disease and immunology; pricing by RFP | Rx Almanac |
| Leadership | Ashar Hasan, CEO; Abbas Mehdi, Chief Product Officer after 11 years as CEO | Company-stated |
| Location | Itasca, IL now; Milpitas, CA in older records | Sources differ |
What to watch
- Any Form D or amended notice that would document the equity holders after the 2025 secondary.
- Whether a manufacturer confirms its Medmonk program publicly, beyond the Grifols portal.
- Whether PitchBook’s Andreessen Horowitz entry is corrected or supported.
- Whether the company discloses revenue or headcount that tests the bootstrapped reading.
The Medmonk story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- IndependentMedmonk funding rounds and investors
- IndependentMedmonk products, financials and headquarters, with news item of Oct 26, 2016
- IndependentMedmonk company profile
- IndependentMedmonk vendor profile
- IndependentMedmonk company page
- InterviewFemale Founder Stories: Somaira Punjwani, Founder of Medmonk (YC W12)
- Public recordParsed SEC Form D and EDGAR mention records for Medmonk, no results
- Public recordCapture history for gamunex-c.medmonk.com
- PartnerXEMBIFY copay assistance portal
- CompanyAbout Us and home page
Compiled from SEC and other public records and published reports as of September 22, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in Medmonk. This page is not an offer to sell or a recommendation to buy any security.
